Ribon Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Ribon Therapeutics's estimated annual revenue is currently $11.8M per year.
- Ribon Therapeutics's estimated revenue per employee is $155,000
- Ribon Therapeutics's total funding is $184M.
Employee Data
- Ribon Therapeutics has 76 Employees.
- Ribon Therapeutics grew their employee count by -4% last year.
Ribon Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP, Corporate Development | Reveal Email/Phone |
2 | Senior Director Clinical Science, Clinical Development | Reveal Email/Phone |
3 | Director | Reveal Email/Phone |
4 | Director, GxP Quality | Reveal Email/Phone |
5 | Clinical Medical Director | Reveal Email/Phone |
6 | Senior Manager Accounting & Reporting | Reveal Email/Phone |
7 | Executive Office Manager | Reveal Email/Phone |
8 | Sr. Clinical Operations Associate | Reveal Email/Phone |
9 | Principal Scientist | Reveal Email/Phone |
10 | Scientist | Reveal Email/Phone |
Ribon Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 15 | -32% | N/A | N/A |
#10 | $10.1M | 48 | -9% | N/A | N/A |
What Is Ribon Therapeutics?
Ribon Therapeutics is a biotech company focused on developing first-in-class therapeutics targeting mono(ADP-ribosyl)ating PARPs for cancer.
keywords:N/A
$184M
Total Funding
76
Number of Employees
$11.8M
Revenue (est)
-4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ribon Therapeutics News
2022-03-30 - Ribon Therapeutics Announces Initiation of Phase 1b/2 Study ...
Ribon Therapeutics is a clinical stage biotechnology company developing therapeutics targeting novel enzyme families activated under cellular...
2022-03-22 - Ribon initiates Phase I trial of atopic dermatitis treatment
Ribon Therapeutics has commenced the healthy volunteer segment of its first-in-human Phase I clinical trial to analyse the potential of its...
2022-03-22 - Ribon Therapeutics Initiates First-in-Human Phase 1 Clinical ...
Ribon Therapeutics is a clinical stage biotechnology company developing therapeutics targeting novel enzyme families activated under cellular...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $20.5M | 76 | 3% | N/A |
#2 | $21.9M | 76 | 25% | N/A |
#3 | $14.9M | 76 | 12% | N/A |
#4 | $12.9M | 76 | -12% | N/A |
#5 | $8.6M | 76 | 29% | N/A |